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THE specificity with which the fluorescent basic dye acridine orange (AO)
combines with nucleic acids, both in vivo and in vitro, has beenreportedby several
workers (de Bruyn, Robertson and Farr, 1950 ; de Bruyn, Farr, Banks and
Morthland, 1953 ; Armstrong, 1956 ; von Bertalanffy et al., 1957 ; Armstrong
and Niven, 1957; Beers, Hendley and Steiner, 1958; Bradley and Wolf, 1960;
Ranadive and Korgaonkar, 1960). This dye is frequently being used as a vital
fluorochrome for staining living cells and tissues (Krebs and Gierlach, 1951 ;
Vinegar, 1956; Ranade, Tatake and Korgaonkar, 1961), which shows that near
physiological pH, at sufficiently low concentrations and when shielded from hght
(Hill, Bensch and King, 1960), it can be non-toxic to hving cells. The growing
malignant tissues are conspicuous by their high stainability with basic dyes. The
localisation ofAO in cancer cells, even in theircytoplasmic areas, has been demon-
strated by von Bertalanffy, Masin and Masin (1958). Such a preferential localisa-
tion of AO suggested the possibility of a selective toxic action on only malignant
cells in the body when the dye is injected in tumour-bearing animals. Investiga-
tions were, therefore, started in this laboratory to study the in vivo effect of AO
on different types of tumours, and the results obtained on Yoshida sarcoma
(ascites) are presented in this communication.
MATERIALS AND METHODS
Analytically pure AO (E. Merck) was dissolved in normal safine at various
concentrationsrangingfrom2to2Oltg./ml. ThepHofthesesolutionswasadjusted
to 7-2 and the solutions were sterilized by autoclaving at 10 lb. pressure for 10
minutes. The animals used in theseexperiments were two months-old Wistar male
rats. Initially the toxicity level of AO in these animals was determined by using body weight as a criterion. In a group of six, each animal was given a single intraperitoneal injection of AO, the quantity of the solution injected being kept proportional to its body weight (0-5 ml. per 100 g.). Different concentrations of
AO were used in different groups ofanimals. Control animals in theseexperiments
received singleinjections ofnormal sterile sahne instead ofAO solutions.
For studies on anti-tumour activity, twenty-four animals at a time were
intraperitoneally injected with aliquots (0-4-0-5 ml.) of ascites fluid proportional
to their bodyweights and then divided into four groups of six animals each. At a
known interval of time after ascites transplantation, three of these groups were
given single intraperitoneal AO injections of doses 1, 1-5 and 2 Itg.1100 g. body weight (b.w.), while thefourth, i.e. the control group receivedonly salineinjections
at the same time. The animals were kept under observation with respect to their472 K. S. KORGAONKAR AND JAYASHREE V. SUKHATANKAR
body weights, ascites fluid formation and survival time. The time intervals
between ascitestransplantation andAOinjection were 0, 8, 24, 30, 36 and 48 hours.
RESULTS
The animals receiving AO doses of 1, 1-5 and 2 Itg.1100 g. (b.w.) showed a
continuous increase in their body weights, comparable to the controls (1-2 g. per
day), while those receiving AO dose of 2-5 /tg./100 g. (b.w.) and above showed a
temporary decrease in theirbodyweights over aperiod of 20-30days. The subse-
quent experiments were, therefore, confined only to the AO doses of 1, 1-5 and 2
Itg.1100 g. (b.w.).
The experimental animals which received AO injections within 36 hours of
ascites transplantation, showed a gradual rise in body weight as expected of
normal animals and almost complete suppression of the fluid formation. So far,
not even a single animal from these groups had died during the entire period of
observation varying from 3 to 8 months. The control animals, on the other hand,
showed arapid rise in bodyweight (about 4 g. per day), formation ofconsiderable
volume offlWd in the abdominalregion and survival time of4/5daysonly (Fig. 1).
When, however, AO injection was given 48 hours after ascites transplantation,
this inhibitory effect decreased considerably and only about 50 per cent of the
animals survived beyond 5 days and none beyond 8 days. Repeated experiments
have confirmed these observations.
In some experiments, animals surviving after 20 days from their first ascites
and AO treatment, weregiven a second ascitestransplantation which was followed
by AO injection at 36 hours interval. Even this time the recovery of the animals
has been as remarkable as before (Fig. 2).
Theseencouraging results havejustified furtherstudy ofthedye as an effective
chemotherapeuticagent in othertypes oftumour also. Such work is in progress.
SUMMARY
The anti-tumour property of fluorescent dye acridine orange (AO) was tested
againsttransplantable Yoshida sarcoma (ascites) tumour in two months old Wistar
male rats. The toxic level ofAO doses for the animals was first determined using
bodyweight as a criterion. Working below this level, at known interval after the
transplantation of the tumour, the animals received intraperitoneal injections of
AO solution 0
-5 ml./100 g. (b.w.) ofthe animal at concentrations 2, 3 and 4#g./ml.,
and pH 7-2.
For anti-tumour property, observations were made on the growth in the
ascites fluid formation, changes in the body weight and life-span of the animals.
EXPLANATION OF PLATE
FIG. I.-(a) Photograph of one ofthe two survivors from a group ofsix rats, 4days after ascites
transplantation.
(b) Photograph ofone of agroup of sixrats, allofwhichsurvived, seven months afterascites
transplantation foRowed by intraperitoneal acridine orange (1-5 [Lg. per 100 g. body weight)
given in solution within 36 hours.
FIG. 2.-A group of six rats which has survived more than six months after two ascites trans-
plantationsseparatedby an interval of 20 days each followed by anintraperitonealinjection
of acridine orange (2 Vg. per 100 g. body weight) given in aqueous solution within 36 hours.
(The animals under a mild anaesthetic effect of other during photography).BRITISII JO-LTRNAL OF CA-WCER. Vol. XVII, No. 3.
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The results show that a single AO injection within 36 hours ofascitestransplanta-
-tion even at the lowest dose used, namely I ug.1100 g. (b.w.), produces complete
-suppression of the ascites fluid formation; while the control animals do not live
beyond 5 days, all the experimental animals used have survived this entire period
-ofobservationextending for more than 4=6 months. Studies on other tumours are
-in progress.
One of us (J.V.S.) expresses her thanks to Dr. B. P. Gothoskar for helpful
-cooperation and to the Government of Maharashtra for the award of a research
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